J L Tessier - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

J L Tessier

Showing results (1-10 of 14) with videos related to

Pageof 2

Sort By:

American Journal of Obstetrics and Gynecology|August 1, 1997

Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertilityG N Smith, M Walker, J L Tessier, et al.

Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990

[T4 and T8 lymphocytic populations after total hip replacement]P Seyral, G Lévy, M Jamet, et al.

Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 1, 2005

Should we resurface the patella in total knee replacement? Experience with the Nex Gen prothesisJ Tabutin, F Banon, Y Catonne, et al.

NMR in Biomedicine|April 27, 2007

Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)D P Bradley, J L Tessier, D Checkley, et al.

Magnetic Resonance Imaging|July 25, 2003

Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenograftsDavid Checkley, Jean J L Tessier, Stephen R Wedge, et al.

The British Journal of Radiology|April 10, 2003

Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting gliomaA Jackson, G C Jayson, K L Li, et al.

The British Journal of Radiology|February 22, 2003

Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI dataK L Li, X P Zhu, D R Checkley, et al.

Presse Medicale (Paris, France : 1983)|October 26, 1991

[Monitoring after total hip prosthesis. Value of semi-quantitative D-dimer assay]G Levy, P Y Levy, P Monin, et al.

Magnetic Resonance Imaging|November 6, 2003

Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast mediaC Pradel, N Siauve, G Bruneteau, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012

First-in-human, phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of RO5126766, a first-in-class dual MEK/RAF inhibitor in patients with solid tumorsMaria Martinez-Garcia, Udai Banerji, Joan Albanell, et al.

Pageof 2

Search research articles

Showing results (1-10 of 14) with videos related to

Sort By:

Pageof 2

American Journal of Obstetrics and Gynecology|August 1, 1997

Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertilityG N Smith, M Walker, J L Tessier, et al.

Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990

[T4 and T8 lymphocytic populations after total hip replacement]P Seyral, G Lévy, M Jamet, et al.

Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 1, 2005

Should we resurface the patella in total knee replacement? Experience with the Nex Gen prothesisJ Tabutin, F Banon, Y Catonne, et al.

NMR in Biomedicine|April 27, 2007

Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)D P Bradley, J L Tessier, D Checkley, et al.

Magnetic Resonance Imaging|July 25, 2003

Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenograftsDavid Checkley, Jean J L Tessier, Stephen R Wedge, et al.

The British Journal of Radiology|April 10, 2003

Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting gliomaA Jackson, G C Jayson, K L Li, et al.

The British Journal of Radiology|February 22, 2003

Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI dataK L Li, X P Zhu, D R Checkley, et al.

Presse Medicale (Paris, France : 1983)|October 26, 1991

[Monitoring after total hip prosthesis. Value of semi-quantitative D-dimer assay]G Levy, P Y Levy, P Monin, et al.

Magnetic Resonance Imaging|November 6, 2003

Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast mediaC Pradel, N Siauve, G Bruneteau, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012

First-in-human, phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of RO5126766, a first-in-class dual MEK/RAF inhibitor in patients with solid tumorsMaria Martinez-Garcia, Udai Banerji, Joan Albanell, et al.

Pageof 2